Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boer, C. J.
Right arrow Articles by Kluin, P. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Boer, C. J.
Right arrow Articles by Kluin, P. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 8:S109-S117, 1997
© 1997 European Society for Medical Oncology

Bcl-1/cyclin D1 in malignant lymphoma

C. J. Boer, J. H. J. M. van Krieken, E. Schuuring and P. M. Kluin

Department of Pathology, Leiden University Hospital Leiden, the Netherlands

Correspondence to: Ph. M. Kluin, MD Laboratory of Pathology Academic Hospital Leiden P.O. Box 9600 2300 RC Leiden The Netherlands

Mantle-cell lymphoma comprises 2%–10% of all non-Hodgkin's lymphomas (NHLs). Patients present with generalized disease, and have a poor prognosis. Three different histologic patterns (mantle zone, nodular, and diffuse) and three different cyto-logical variants (classical, blastic, and pleomorphic) have been described. The phenotype (strong surface IgM, CD5+, CD10–, CD23–, cyclin D1+ and B-cell markers+) is remarkably constant. Dependent on the methods used (PCR, Southern blot analysis, and cytogenetics) a t(11;14) can be detected in approximately 35%–66% of cases. Using FISH analysis, possibly almost all cyclin D1-expressing MCLs carry this translocation, indicating that a substantial part of these translocations are missed by conventional methods. This has been confirmed by DNA fiber FISH analysis by which the breakpoints could be accurately mapped over a 220 kb region centromeric of the cyclin D1 gene. Additional genetic abnormalities involve breakpoints and deletion at the 3' end of the cyclin D1 gene, numerical chromosomal aberrations, mutations in p53, and deletions of pl6. These may be associated with tumor progression. Owing to the translocation t(11;14), the cyclin D1 gene is activated. At the RNA level, approximately 90% of MCLs show overexpression. This corroborates immunohistochemistry on paraffin tissue sections. Since expression of cyclin D1 in normal lymphoid cells is very low to undetectable, and only hairy-cell leukemia and very few other B-cell lymphomas show expression, immunohistochemistry for cyclin D1 provides an excellent marker for MCL. In hairy-cell leukemia, expression is moderate and cannot be explained by chromosomal translocation.

bcl-1, centrocytic lymphoma, cyclin D1, hairy-cell leukemia, mantle-cell lymphoma, review, 11q13, t(11;14)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
K E Hunt, K K Reichard, and C S Wilson
Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature
J. Clin. Pathol., July 1, 2008; 61(7): 869 - 870.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.